Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Gajofatto

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Disease Markers|December 11, 2013
Clinical, MRI, and CSF markers of disability progression in multiple sclerosisAlberto Gajofatto, Massimiliano Calabrese, Maria Donata Benedetti, et al.
Clinical & Developmental Immunology|August 18, 2012
HCV-related nervous system disordersSalvatore Monaco, Sergio Ferrari, Alberto Gajofatto, et al.
European Neurology|September 18, 2014
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational studyAlberto Gajofatto, Maria Rachele Bianchi, Luciano Deotto, et al.
International Journal of Molecular Sciences|December 17, 2011
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients?Alberto Gajofatto, Matilde Bongianni, Gianluigi Zanusso, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 13, 2010
Long survival and clinical stability in Marburg's variant multiple sclerosisMarco Turatti, Alberto Gajofatto, Francesca Rossi, et al.
BMC Neurology|March 29, 2023
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticityAlberto Gajofatto, Nicolò Cardobi, Francesca Gobbin, et al.
International Journal of Molecular Sciences|September 13, 2025
Serum Levels of miR-34a-5p, miR-30b-5p, and miR-140-5p Are Associated with Disease Activity and Brain Atrophy in Early Multiple SclerosisRiccardo Orlandi, Leopoldo Torresan, Francesca Gobbin, et al.
Healthcare (Basel, Switzerland)|September 27, 2025
Psychosocial Correlates of Fatigue in Young Adults with Multiple Sclerosis: Exploring the Roles of Resilience, Mindfulness, and Illness PerceptionSilvia Poli, Valeria Donisi, Roshan das Nair, et al.
Journal of the Neurological Sciences|November 16, 2012
Benign course of tumour-like multiple sclerosis. Report of five cases and literature reviewMarco Turatti, Alberto Gajofatto, Maria Rachele Bianchi, et al.
Journal of Neurology|April 12, 2011
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP scorePaolo Invernizzi, Laura Bertolasi, Maria Rachele Bianchi, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Disease Markers|December 11, 2013
Clinical, MRI, and CSF markers of disability progression in multiple sclerosisAlberto Gajofatto, Massimiliano Calabrese, Maria Donata Benedetti, et al.
Clinical & Developmental Immunology|August 18, 2012
HCV-related nervous system disordersSalvatore Monaco, Sergio Ferrari, Alberto Gajofatto, et al.
European Neurology|September 18, 2014
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational studyAlberto Gajofatto, Maria Rachele Bianchi, Luciano Deotto, et al.
International Journal of Molecular Sciences|December 17, 2011
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients?Alberto Gajofatto, Matilde Bongianni, Gianluigi Zanusso, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 13, 2010
Long survival and clinical stability in Marburg's variant multiple sclerosisMarco Turatti, Alberto Gajofatto, Francesca Rossi, et al.
BMC Neurology|March 29, 2023
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticityAlberto Gajofatto, Nicolò Cardobi, Francesca Gobbin, et al.
International Journal of Molecular Sciences|September 13, 2025
Serum Levels of miR-34a-5p, miR-30b-5p, and miR-140-5p Are Associated with Disease Activity and Brain Atrophy in Early Multiple SclerosisRiccardo Orlandi, Leopoldo Torresan, Francesca Gobbin, et al.
Healthcare (Basel, Switzerland)|September 27, 2025
Psychosocial Correlates of Fatigue in Young Adults with Multiple Sclerosis: Exploring the Roles of Resilience, Mindfulness, and Illness PerceptionSilvia Poli, Valeria Donisi, Roshan das Nair, et al.
Journal of the Neurological Sciences|November 16, 2012
Benign course of tumour-like multiple sclerosis. Report of five cases and literature reviewMarco Turatti, Alberto Gajofatto, Maria Rachele Bianchi, et al.
Journal of Neurology|April 12, 2011
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP scorePaolo Invernizzi, Laura Bertolasi, Maria Rachele Bianchi, et al.
Pageof 9